Author:
Fukuma Ryohei,Yanagisawa Takufumi,Kinoshita Manabu,Shinozaki Takashi,Arita Hideyuki,Kawaguchi Atsushi,Takahashi Masamichi,Narita Yoshitaka,Terakawa Yuzo,Tsuyuguchi Naohiro,Okita Yoshiko,Nonaka Masahiro,Moriuchi Shusuke,Takagaki Masatoshi,Fujimoto Yasunori,Fukai Junya,Izumoto Shuichi,Ishibashi Kenichi,Nakajima Yoshikazu,Shofuda Tomoko,Kanematsu Daisuke,Yoshioka Ema,Kodama Yoshinori,Mano Masayuki,Mori Kanji,Ichimura Koichi,Kanemura Yonehiro,Kishima Haruhiko
Abstract
AbstractIdentification of genotypes is crucial for treatment of glioma. Here, we developed a method to predict tumor genotypes using a pretrained convolutional neural network (CNN) from magnetic resonance (MR) images and compared the accuracy to that of a diagnosis based on conventional radiomic features and patient age. Multisite preoperative MR images of 164 patients with grade II/III glioma were grouped by IDH and TERT promoter (pTERT) mutations as follows: (1) IDH wild type, (2) IDH and pTERT co-mutations, (3) IDH mutant and pTERT wild type. We applied a CNN (AlexNet) to four types of MR sequence and obtained the CNN texture features to classify the groups with a linear support vector machine. The classification was also performed using conventional radiomic features and/or patient age. Using all features, we succeeded in classifying patients with an accuracy of 63.1%, which was significantly higher than the accuracy obtained from using either the radiomic features or patient age alone. In particular, prediction of the pTERT mutation was significantly improved by the CNN texture features. In conclusion, the pretrained CNN texture features capture the information of IDH and TERT genotypes in grade II/III gliomas better than the conventional radiomic features.
Funder
Japan Science and Technology Corporation
Terumo Foundation for Life Sciences and Arts
the Ministry of Health, Labor, and Welfare
Japan Foundation of Aging and Health
The Canon Foundation
Japan Society for the Promotion of Science
MSD Life Science Foundation
Research Grant from the Takeda Science Foundation
the Uehara Memorial Foundation
NIBIOHN
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC